Upexi UPXI Non Cash Proceeds In The Sale Of Vitamedica
Non Cash Proceeds In The Sale Of Vitamedica at other companies
Other financials
Where this comes from
Reported directly by Upexi in its filing.
Tagged under the XBRL concept upxi:NonCashProceedsInTheSaleOfVitamedica.
The official record: Upexi’s 10-K, filed September 24, 2025, on SEC EDGAR. View the filing →
Ask your AI about Upexi's non cash proceeds in the sale of vitamedica.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Upexi's non cash proceeds in the sale of vitamedica?
- Upexi (UPXI) reported non cash proceeds in the sale of vitamedica of $0 in Q2 2025.
- How has Upexi's non cash proceeds in the sale of vitamedica changed year-over-year?
- Upexi's non cash proceeds in the sale of vitamedica decreased by 100.0% year-over-year, from $475K to $0.
- What does non cash proceeds in the sale of vitamedica mean?
- Captures the value of non-cash consideration received, such as notes receivable or equity in another entity, resulting from the divestiture of a business unit. This metric is essential for understanding the true economic value realized from asset sales beyond immediate cash inflows.